iRhythm Technologies, Inc.
General ticker "IRTC" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $4.2B (TTM average)
iRhythm Technologies, Inc. follows the US Stock Market performance with the rate: 58.0%.
Estimated limits based on current volatility of 5.1%: low 156.57$, high 173.54$
Factors to consider:
- Total employees count: 2000 as of 2024
- Top business risk factors: Reimbursement risks, Labor/talent shortage/retention, Management stability, Geopolitical risks, Collection risk
- Current price 66.7% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [47.88$, 118.85$]
- 2025-12-31 to 2026-12-31 estimated range: [39.35$, 100.27$]
Financial Metrics affecting the IRTC estimates:
- Negative: with PPE of -26.6 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Shareholder equity ratio, % of 9.76 <= 19.35
- Positive: Industry inventory ratio change (median), % of -1.22 <= -0.18
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0.46 <= 0.74
- Positive: -14.19 < Investing cash flow per share per price, % of -4.45
Short-term IRTC quotes
Long-term IRTC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $410.92MM | $492.68MM | $591.84MM |
| Operating Expenses | $524.71MM | $617.84MM | $707.34MM |
| Operating Income | $-113.78MM | $-125.16MM | $-115.50MM |
| Non-Operating Income | $-2.10MM | $2.50MM | $2.78MM |
| Interest Expense | $4.14MM | $3.65MM | $12.82MM |
| R&D Expense | $46.61MM | $60.24MM | $71.46MM |
| Income(Loss) | $-115.89MM | $-122.66MM | $-112.72MM |
| Taxes | $0.27MM | $0.75MM | $0.56MM |
| Profit(Loss)* | $-116.16MM | $-123.41MM | $-226.58MM |
| Stockholders Equity | $239.81MM | $210.10MM | $90.91MM |
| Inventory | $15.15MM | $13.97MM | $14.04MM |
| Assets | $448.22MM | $433.14MM | $931.45MM |
| Operating Cash Flow | $-23.01MM | $-50.10MM | $3.39MM |
| Capital expenditure | $29.83MM | $40.42MM | $33.94MM |
| Investing Cash Flow | $-52.43MM | $-1.21MM | $-122.98MM |
| Financing Cash Flow | $26.72MM | $8.82MM | $511.38MM |
| Earnings Per Share** | $-3.88 | $-4.04 | $-7.26 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.